Abstract

I argue that harm reduction programs should be extended to include psychedelic drugs. I reach this conclusion by first defining harm reduction and discussing arguments in favor of harm reduction for drug use in general. I offer defenses of harm reduction for drug use on the basis of consequentialism, Kantianism/deontology, and virtue ethics. I then apply this reasoning to harm reduction for psychedelic drugs, while also arguing that these programs are easier to defend than harm reduction for other, harder drugs and that these programs could be easily implemented.